These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 7619525)

  • 1. Characterization of stable complexes involving apolipoprotein E and the amyloid beta peptide in Alzheimer's disease brain.
    Näslund J; Thyberg J; Tjernberg LO; Wernstedt C; Karlström AR; Bogdanovic N; Gandy SE; Lannfelt L; Terenius L; Nordstedt C
    Neuron; 1995 Jul; 15(1):219-28. PubMed ID: 7619525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity.
    de Jager M; Drukarch B; Hofstee M; Brevé J; Jongenelen CA; Bol JG; Wilhelmus MM
    J Neurochem; 2015 Sep; 134(6):1116-28. PubMed ID: 26088696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoform-specific binding of human apolipoprotein E to the non-amyloid beta component of Alzheimer's disease amyloid.
    Olesen OF; Mikkelsen JD; Gerdes C; Jensen PH
    Brain Res Mol Brain Res; 1997 Feb; 44(1):105-12. PubMed ID: 9030704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interaction between apolipoprotein E and Alzheimer's amyloid beta-peptide is dependent on beta-peptide conformation.
    Golabek AA; Soto C; Vogel T; Wisniewski T
    J Biol Chem; 1996 May; 271(18):10602-6. PubMed ID: 8631862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular modeling of apoE in complexes with Alzheimer's amyloid-β fibrils from human brain suggests a structural basis for apolipoprotein co-deposition with amyloids.
    Lewkowicz E; Nakamura MN; Rynkiewicz MJ; Gursky O
    Cell Mol Life Sci; 2023 Nov; 80(12):376. PubMed ID: 38010414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposite roles of apolipoprotein E in normal brains and in Alzheimer's disease.
    Russo C; Angelini G; Dapino D; Piccini A; Piombo G; Schettini G; Chen S; Teller JK; Zaccheo D; Gambetti P; Tabaton M
    Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15598-602. PubMed ID: 9861015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.
    Strittmatter WJ; Weisgraber KH; Huang DY; Dong LM; Salvesen GS; Pericak-Vance M; Schmechel D; Saunders AM; Goldgaber D; Roses AD
    Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8098-102. PubMed ID: 8367470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E and beta-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoprotein E genotype dependent.
    Beffert U; Cohn JS; Petit-Turcotte C; Tremblay M; Aumont N; Ramassamy C; Davignon J; Poirier J
    Brain Res; 1999 Oct; 843(1-2):87-94. PubMed ID: 10528114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E.
    Castano EM; Prelli F; Wisniewski T; Golabek A; Kumar RA; Soto C; Frangione B
    Biochem J; 1995 Mar; 306 ( Pt 2)(Pt 2):599-604. PubMed ID: 7534068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haptoglobin interacts with apolipoprotein E and beta-amyloid and influences their crosstalk.
    Spagnuolo MS; Maresca B; La Marca V; Carrizzo A; Veronesi C; Cupidi C; Piccoli T; Maletta RG; Bruni AC; Abrescia P; Cigliano L
    ACS Chem Neurosci; 2014 Sep; 5(9):837-47. PubMed ID: 25058565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E and Alzheimer's disease. A role in amyloid catabolism.
    Poirier J
    Ann N Y Acad Sci; 2000; 924():81-90. PubMed ID: 11193807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A synthetic peptide blocking the apolipoprotein E/beta-amyloid binding mitigates beta-amyloid toxicity and fibril formation in vitro and reduces beta-amyloid plaques in transgenic mice.
    Sadowski M; Pankiewicz J; Scholtzova H; Ripellino JA; Li Y; Schmidt SD; Mathews PM; Fryer JD; Holtzman DM; Sigurdsson EM; Wisniewski T
    Am J Pathol; 2004 Sep; 165(3):937-48. PubMed ID: 15331417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ApoE immunoreactivity and microglial cells in Alzheimer's disease brain.
    Uchihara T; Duyckaerts C; He Y; Kobayashi K; Seilhean D; Amouyel P; Hauw JJ
    Neurosci Lett; 1995 Jul; 195(1):5-8. PubMed ID: 7478253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human cerebrospinal fluid apolipoprotein E isoforms are apparently inefficient at complexing with synthetic Alzheimer's amyloid-[beta] peptide (A[beta] 1-40 ) in vitro.
    Zhou Z; Relkin N; Ghiso J; Smith JD; Gandy S
    Mol Med; 2002 Jul; 8(7):376-81. PubMed ID: 12393935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astrocyte-apolipoprotein E associations in senile plaques in Alzheimer disease and vascular lesions: a regional immunohistochemical study.
    Shao Y; Gearing M; Mirra SS
    J Neuropathol Exp Neurol; 1997 Apr; 56(4):376-81. PubMed ID: 9100668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer amyloid-beta peptide forms denaturant-resistant complex with type epsilon 3 but not type epsilon 4 isoform of native apolipoprotein E.
    Zhou Z; Smith JD; Greengard P; Gandy S
    Mol Med; 1996 Mar; 2(2):175-80. PubMed ID: 8726460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotype-related differences of hippocampal apolipoprotein E levels only in early stages of neuropathological changes in Alzheimer's disease.
    Glöckner F; Meske V; Ohm TG
    Neuroscience; 2002; 114(4):1103-14. PubMed ID: 12379263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3.
    Sanan DA; Weisgraber KH; Russell SJ; Mahley RW; Huang D; Saunders A; Schmechel D; Wisniewski T; Frangione B; Roses AD
    J Clin Invest; 1994 Aug; 94(2):860-9. PubMed ID: 8040342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon4 allele.
    Vidal R; Calero M; Piccardo P; Farlow MR; Unverzagt FW; Méndez E; Jiménez-Huete A; Beavis R; Gallo G; Gomez-Tortosa E; Ghiso J; Hyman BT; Frangione B; Ghetti B
    Acta Neuropathol; 2000 Jul; 100(1):1-12. PubMed ID: 10912914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of apolipoprotein E in Alzheimer's disease and its significance].
    He SR; Liu DG; Wang S; Xia YJ
    Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.